BIO-CAT is pleased to announce the hiring of Elaine Cooling as regulatory affairs manager. Elaine comes to BIO-CAT with over 15 years’ experience in quality, regulatory and manufacturing support roles primarily in the pharmaceutical industry, most recently with Allergen Pharmaceuticals International. Elaine’s role will oversee the daily regulatory needs of BIO-CAT’s customers, play a vital […]
The facility will address increasing demand for small-volume mAb CDMO services Lyon, France – Novasep, a leading supplier of services and technologies for the life sciences industry, announces a €17M investment in a dedicated GMP mAb production facility. The facility will be located in Pompey (FR) and will be operational by mid-2019. The investment, part of […]
ProMab Biotechnologies, a manufacturer of monoclonal antibodies and immunotherapy related products and services, has acquired One World Lab, a marketplace exclusive to manufacturers. SAN DIEGO One World Lab, Inc., (OWL) had been operating for over 5 years developing a marketplace based on the belief that there needs to be transparency in life science research. To […]
The GSK enables a new user to learn how to characterize small molecules using the breakthrough kinetic binding platform in under four hours. San Diego, CA Nanomedical Diagnostics, a cutting-edge life science company pioneering graphene biosensors that accelerate pharmaceutical and biotherapeutics development, announces the launch of the new Getting Started Kit (GSK), a self-training package […]
IPSWICH, Mass. and VILNIUS, Lithuania — New England Biolabs, Inc. (NEB®) and CasZyme, a recently-formed startup company based in Vilnius, Lithuania, announced today that they have entered into a multi-year collaboration to identify and commercialize CRISPR-Cas nucleases, with the goal of providing researchers with additional tools for genome editing and molecular biology applications. Under the terms of the agreement, […]
Emeryville, Calif. – Berkeley Lights, Inc. (BLI), a company dedicated to bringing to market transformational platforms for biopharmaceutical processes, announced today that Teva Pharmaceuticals Australia, Pty. Ltd. has implemented BLI’s Beacon platform in their antibody discovery programs. The Beacon platform is capable of screening thousands of antibody producing cells in less than a day. Cell characterizations […]
Heidelberg, Germany and Cambridge, UK – SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it has signed a supply agreement with US Biological, Salem, MA, USA, for its Innova Lightning-Link® technology. Heikki Lanckriet, CEO and CSO of SYGNIS AG, commented: “We are […]
Accelerates growth in cell analysis, new technology and market development PEARLAND, Texas–Base Pair Biotechnologies, Inc., The Aptamer Discovery Company™, today announced the completion of its $3.2 Million Series A-3 financing round and the opening of its new 5,000 square foot laboratory and office facility in Pearland, TX, a Houston suburb. Toronto-based Eventi Capital Partners Inc. […]
MADISON, WI USA Promega Corporation’s new NanoBRET™ Target Engagement (TE) Intracellular Kinase Assay is the first assay to quantify inhibitor drug binding to kinase proteins inside live human cells, as demonstrated in the recent Cell Chemical Biology article, “Quantitative, Wide-spectrum Kinase Profiling in Live Cells for Assessing the Effect of Cellular ATP on Target Engagement.” In collaboration […]
LEXINGTON, Mass.—-Quanterix Corporation, a company with a next generation, ultra-sensitive digital platform that advances precision health, today announced the commencement of the initial public offering of shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the “Commission”). The offering consists of 3,340,000 shares of common stock […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
